This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Rukundo Ntaganda: Innovator in Pharmaceutical Chemistry
Introduction
Rukundo Ntaganda is a notable inventor based in Weymouth, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds.
Latest Patents
Ntaganda holds a patent for "Urea compounds and compositions as SMARCA2/BRM ATPase inhibitors." This patent outlines a method of preparing a compound of Formula (I), or a pharmaceutically acceptable salt thereof, wherein R through R are defined in the documentation. He has 1 patent to his name, showcasing his expertise in this specialized area.
Career Highlights
Currently, Rukundo Ntaganda is employed at Novartis AG, a leading global healthcare company. His work focuses on developing new therapeutic solutions that address critical health challenges.
Collaborations
Throughout his career, Ntaganda has collaborated with esteemed colleagues, including Christopher Adair and Katsumasa Nakajima. These partnerships have further enhanced his research and innovation efforts.
Conclusion
Rukundo Ntaganda is a dedicated inventor whose work in pharmaceutical chemistry continues to impact the industry positively. His innovative approach and collaboration with other experts highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile